TG13 antimicrobial therapy for acute cholangitis and cholecystitis
- 11 January 2013
- journal article
- practice guideline
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 20 (1) , 60-70
Abstract
Therapy with appropriate antimicrobial agents is an important component in the management of patients with acute cholangitis and/or acute cholecystitis. In the updated Tokyo Guidelines (TG13), we recommend antimicrobial agents that are suitable from a global perspective for management of these infections. These recommendations focus primarily on empirical therapy (presumptive therapy), provided before the infecting isolates are identified. Such therapy depends upon knowledge of both local microbial epidemiology and patient‐specific factors that affect selection of appropriate agents. These patient‐specific factors include prior contact with the health care system, and we separate community‐acquired versus healthcare‐associated infections because of the higher risk of resistance in the latter. Selection of agents for community‐acquired infections is also recommended on the basis of severity (grades I‐III).Keywords
This publication has 53 references indexed in Scilit:
- Editorial Commentary: Asking the Right Questions: Morbidity, Mortality, and Measuring What's Important in Unbiased Evaluations of AntimicrobialsClinical Infectious Diseases, 2012
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority TrialsClinical Infectious Diseases, 2012
- Molecular Epidemiology over an 11-Year Period (2000 to 2010) of Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Bacteremia in a Centralized Canadian RegionJournal of Clinical Microbiology, 2012
- Two cases of monomicrobial intraabdominal abscesses due to KPC - 3 Klebsiella pneumoniaeST258 cloneBMC Gastroenterology, 2011
- Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)-Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258Clinical Infectious Diseases, 2011
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomesPostgraduate Medical Journal, 2007
- Antimicrobial therapy for acute cholecystitis: Tokyo GuidelinesJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Antimicrobial therapy for acute cholangitis: Tokyo GuidelinesJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin???Tazobactam and Amoxicillin???Clavulanate for the Treatment of Complicated Intra-abdominal InfectionsAnnals of Surgery, 2006